Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies.

Authors	Hanny Al-Samkari
Journal	Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (Otolaryngol Head Neck Surg) Vol. 160 Issue 2 Pg. 368 (02 2019) ISSN: 1097-6817 [Electronic] England
PMID	30798765 (Publication Type: Letter, Comment)
Chemical References	Angiogenesis Inhibitors Bevacizumab
Topics	Angiogenesis Inhibitors Bevacizumab Epistaxis Humans Telangiectasia, Hereditary Hemorrhagic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!